Literature DB >> 21044048

Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone.

Panchanan Maiti1, Roberto Piacentini, Cristian Ripoli, Claudio Grassi, Gal Bitan.   

Abstract

Aβ (amyloid β-peptide) is believed to cause AD (Alzheimer's disease). Aβ42 (Aβ comprising 42 amino acids) is substantially more neurotoxic than Aβ40 (Aβ comprising 40 amino acids), and this increased toxicity correlates with the existence of unique Aβ42 oligomers. Met³⁵ oxidation to sulfoxide or sulfone eliminates the differences in early oligomerization between Aβ40 and Aβ42. Met³⁵ oxidation to sulfoxide has been reported to decrease Aβ assembly kinetics and neurotoxicity, whereas oxidation to sulfone has rarely been studied. Based on these data, we expected that oxidation of Aβ to sulfone would also decrease its toxicity and assembly kinetics. To test this hypothesis, we compared systematically the effect of the wild-type, sulfoxide and sulfone forms of Aβ40 and Aβ42 on neuronal viability, dendritic spine morphology and macroscopic Ca²(+) currents in primary neurons, and correlated the data with assembly kinetics. Surprisingly, we found that, in contrast with Aβ-sulfoxide, Aβ-sulfone was as toxic and aggregated as fast, as wild-type Aβ. Thus, although Aβ-sulfone is similar to Aβ-sulfoxide in its dipole moment and oligomer size distribution, it behaves similarly to wild-type Aβ in its aggregation kinetics and neurotoxicity. These surprising data decouple the toxicity of oxidized Aβ from its initial oligomerization, and suggest that our current understanding of the effect of methionine oxidation in Aβ is limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21044048      PMCID: PMC5767168          DOI: 10.1042/BJ20101391

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization.

Authors:  Gal Bitan; Bogdan Tarus; Sabrina S Vollers; Hilal A Lashuel; Margaret M Condron; John E Straub; David B Teplow
Journal:  J Am Chem Soc       Date:  2003-12-17       Impact factor: 15.419

Review 2.  The C-terminus of the beta protein is critical in amyloidogenesis.

Authors:  J T Jarrett; E P Berger; P T Lansbury
Journal:  Ann N Y Acad Sci       Date:  1993-09-24       Impact factor: 5.691

Review 3.  The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  Biochim Biophys Acta       Date:  2004-11-20

4.  Methionine regulates copper/hydrogen peroxide oxidation products of Abeta.

Authors:  Feda E Ali; Frances Separovic; Colin J Barrow; Robert A Cherny; Fiona Fraser; Ashley I Bush; Colin L Masters; Kevin J Barnham
Journal:  J Pept Sci       Date:  2005-06       Impact factor: 1.905

5.  Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization.

Authors:  Gal Bitan; Sabrina S Vollers; David B Teplow
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

6.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

7.  In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid beta-peptide of APP.

Authors:  D Allan Butterfield; Veronica Galvan; Miranda Bader Lange; Huidong Tang; Renã A Sowell; Patricia Spilman; Joanna Fombonne; Olivia Gorostiza; Junli Zhang; Rukhsana Sultana; Dale E Bredesen
Journal:  Free Radic Biol Med       Date:  2009-10-23       Impact factor: 7.376

8.  Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function.

Authors:  Francesco Misiti; M Elisabetta Clementi; Bruno Giardina
Journal:  Neurochem Int       Date:  2010-01-11       Impact factor: 3.921

9.  C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity.

Authors:  Erica A Fradinger; Bernhard H Monien; Brigita Urbanc; Aleksey Lomakin; Miao Tan; Huiyuan Li; Sean M Spring; Margaret M Condron; Luis Cruz; Cui-Wei Xie; George B Benedek; Gal Bitan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

10.  Dendrites, dementia and the Down syndrome.

Authors:  S Takashima; A Ieshima; H Nakamura; L E Becker
Journal:  Brain Dev       Date:  1989       Impact factor: 1.961

View more
  11 in total

1.  Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity.

Authors:  Robin Roychaudhuri; Xueyun Zheng; Aleksey Lomakin; Panchanan Maiti; Margaret M Condron; George B Benedek; Gal Bitan; Michael T Bowers; David B Teplow
Journal:  ACS Chem Neurosci       Date:  2015-10-19       Impact factor: 4.418

2.  Design of β-amyloid aggregation inhibitors from a predicted structural motif.

Authors:  Paul A Novick; Dahabada H Lopes; Kim M Branson; Alexandra Esteras-Chopo; Isabella A Graef; Gal Bitan; Vijay S Pande
Journal:  J Med Chem       Date:  2012-03-15       Impact factor: 7.446

3.  Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo.

Authors:  Jackob Moskovitz; Panchanan Maiti; Dahabada H J Lopes; Derek B Oien; Aida Attar; Tingyu Liu; Shivina Mittal; Jane Hayes; Gal Bitan
Journal:  Biochemistry       Date:  2011-11-14       Impact factor: 3.162

4.  Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons.

Authors:  Roberto Piacentini; Domenica Donatella Li Puma; Marco Mainardi; Giacomo Lazzarino; Barbara Tavazzi; Ottavio Arancio; Claudio Grassi
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

5.  Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers.

Authors:  Aida Attar; Cristian Ripoli; Elisa Riccardi; Panchanan Maiti; Domenica D Li Puma; Tingyu Liu; Jane Hayes; Mychica R Jones; Kristin Lichti-Kaiser; Fusheng Yang; Greg D Gale; Chi-Hong Tseng; Miao Tan; Cui-Wei Xie; Jeffrey L Straudinger; Frank-Gerrit Klärner; Thomas Schrader; Sally A Frautschy; Claudio Grassi; Gal Bitan
Journal:  Brain       Date:  2012-11-26       Impact factor: 13.501

6.  Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicity.

Authors:  Javier Martínez; Silvia Lisa; Rosa Sánchez; Wioleta Kowalczyk; Esther Zurita; Meritxell Teixidó; Ernest Giralt; David Andreu; Jesús Avila; María Gasset
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

Review 7.  HSV-1 and Alzheimer's disease: more than a hypothesis.

Authors:  Roberto Piacentini; Giovanna De Chiara; Domenica D Li Puma; Cristian Ripoli; Maria E Marcocci; Enrico Garaci; Anna T Palamara; Claudio Grassi
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

8.  Solid Lipid Curcumin Particles Induce More DNA Fragmentation and Cell Death in Cultured Human Glioblastoma Cells than Does Natural Curcumin.

Authors:  Panchanan Maiti; Abeer Al-Gharaibeh; Nivya Kolli; Gary L Dunbar
Journal:  Oxid Med Cell Longev       Date:  2017-11-19       Impact factor: 6.543

9.  Comparison of three amyloid assembly inhibitors: the sugar scyllo-inositol, the polyphenol epigallocatechin gallate, and the molecular tweezer CLR01.

Authors:  Sharmistha Sinha; Zhenming Du; Panchanan Maiti; Frank-Gerrit Klärner; Thomas Schrader; Chunyu Wang; Gal Bitan
Journal:  ACS Chem Neurosci       Date:  2012-03-07       Impact factor: 5.780

10.  Comparative Neuroprotective Effects of Dietary Curcumin and Solid Lipid Curcumin Particles in Cultured Mouse Neuroblastoma Cells after Exposure to Aβ42.

Authors:  Panchanan Maiti; Gary L Dunbar
Journal:  Int J Alzheimers Dis       Date:  2017-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.